-
Diagnostics World | The impact of the throat microbiome on the health of older individuals has gone unappreciated, especially among individuals being cared for in long-term care facilities. One big reason is that they are largely isolated and often forgotten by the public, even as these facilities have become home to a greater proportion of the overall population.
Apr 8, 2025
-
Diagnostics World | Atrial Fibrillation (AFib) is a fast-growing public health crisis—three times more common than once thought. Today, at least 10.55 million US adults have AFib, far exceeding the 3.3 million cases researchers predicted for the year 2020 in 1996. And this crisis is only growing.
Apr 4, 2025
-
Diagnostics World | Last week, Babson Diagnostics entered an agreement with Sam’s Club to offer BetterWay blood testing. BetterWay is currently available in seven Sam’s Club pharmacies in the greater Austin area. The agreement with Sam’s Club marks a significant milestone for accessible blood testing for patients.
Apr 3, 2025
-
Diagnostics World | The U.S. District Court for the Eastern District of Texas granted a motion for summary judgment yesterday, vacating the FDA rule that would have regulated LDTs as medical devices under the Federal Food, Drug and Cosmetic Act.
Apr 1, 2025
-
Diagnostics World | PathAI received full qualification for AIM-MASH AI Assist1; Mayo Clinic Laboratories and Amprion announced a collaboration to expand access to Amprion's SAAmplify–αSYN (CSF) test across the United States; and more.
Mar 27, 2025
-
Diagnostics World | Curevo will advance development of amezosvatein, the company’s vaccine for shingles; Garuda aims to address the growing need for off-the-shelf and cost-effective solution to stem cell transplants; and more.
Mar 26, 2025
-
Diagnostics World | GE HealthCare announced a collaboration this week with NVIDIA, expanding the existing 16-year relationship between the two companies to focus on pioneering innovation in autonomous imaging, beginning with autonomous X-ray technologies and autonomous applications within ultrasound.
Mar 20, 2025
-
Diagnostics World | Based on the discovery that the adhesion strength of cancer cells scales inversely proportional to the invasiveness of a tumor, researchers at University of California, San Diego have built a microfluidic device with the hope that it can be used in the future to diagnose the metastatic potential of ductal carcinoma in situ (DCIS) breast cancer tumors.
Mar 19, 2025
-
Diagnostics World | The incidence of bladder cancer is rising significantly due to population aging and, while survival rates are relatively high, when diagnosed late patients may need to undergo bladder removal regardless of survival. Early detection and treatment of bladder cancer are therefore crucial to preserving the organ and maintaining the patient’s quality of life.
Mar 18, 2025
-
Diagnostics World | Altitude Lab, a nonprofit established by biotech company Recursion, has launched a pre-seed venture fund aimed at supporting 10 to 15 early-stage startups navigating the current uncertainty surrounding government funding. Executive Director Chandana Haque hopes other private investment groups will follow suit to bridge the gap left by disrupted Small Business Innovation Research (SBIR) grants, which have historically been crucial in launching startups and securing follow-on investments.
Mar 13, 2025
-
Diagnostics World | A new platelet function test has been developed by researchers in the UK that could help pharmaceutical companies design better, safer drugs for the prevention of heart attacks and strokes and, longer term, to help doctors know which of their high-risk patients should be put on blood thinners. Ultimately, the test could be developed into a point-of-care preventive diagnostic for the general population that’s as simple to use as a blood glucose fingerprick test.
Mar 11, 2025
-
Diagnostics World | A retrospective study from Personalis for its NeXT Personal test, an ultra-sensitive circulating tumor DNA (ctDNA) test for cancer patients and survivors, has been published in Annals of Oncology. The study was conducted with researchers from The Institute of Cancer Research, London and The Royal Marsden NHS Foundation Trust in the UK.
Mar 6, 2025
-
Diagnostics World | In a paper published last month in Nature Scientific Reports, authors validate Northstar Response, BillionToOne's novel tissue-free circulating tumor DNA (ctDNA) liquid biopsy test that enables physicians to monitor cancer treatment response in Stage III-IV cancers with a blood draw.
Mar 5, 2025
-
Diagnostics World | A transcontinental collaborative effort brought together 300 experts from 12 European countries and Canada to try and crack the genetic cause of thousands of unsolved rare disease cases. Through data-sharing and genetic reanalysis, this “coalition of the willing” has most recently succeeded in providing more than 500 patients with a long-awaited diagnosis—and peace of mind to unaffected family members about whether they carry the risk variant.
Mar 4, 2025
-
Diagnostics World | Dovetail Genomics announced its early access services for FFPE (Formalin-Fixed Paraffin-Embedded) sample analysis; Cellino announced its collaboration with Mass General Brigham’s Gene and Cell Therapy Institute (GCTI) to launch the world’s first hospital-based autologous induced pluripotent stem cell (iPSC) Foundry; and more.
Feb 27, 2025
-
Diagnostics World | A transcontinental collaborative effort brought together 300 experts from 12 European countries and Canada to try and crack the genetic cause of thousands of unsolved rare disease cases. Through data-sharing and genetic reanalysis, this “coalition of the willing” has most recently succeeded in providing more than 500 patients with a long-awaited diagnosis—and peace of mind to unaffected family members about whether they carry the risk variant.
Feb 26, 2025
-
Diagnostics World | Researchers at the University of Cambridge have developed washable and comfortable ‘smart pajamas’ to help monitor sleep disorders at home. The pajamas negate the need for sticky patches, monitoring equipment, or visiting sleep clinics for specialty tests.
Feb 20, 2025
-
Diagnostics World | Amid an industrywide shortage of workers and hospital capacity, a multimodal artificial intelligence (AI) platform providing real-time visibility into the clinical picture for patients is finding a national audience with health systems big and small who want to “make the right thing the easy thing to do” for their overburdened clinicians.
Feb 13, 2025
-
Diagnostics World | Two glycans are better than one when it comes to detecting pancreatic cancer that currently lacks a biomarker capable of accurately and reliably spotting the disease. The gold standard biomarker CA19-9, approved by the U.S. Food and Drug Administration (FDA) for monitoring response to treatment, correctly identifies only 44% of cases but the addition of CA199.STRA ramped that up to 71% while maintaining a low false positive rate in a recent case control study.
Feb 11, 2025
-
Diagnostics World | Physiological changes in the body driven by inflammation, as happens with inflammatory bowel disease (IBD) and rheumatoid arthritis, can be “easily and passively” measured with commercially available wearable devices, according to gastroenterologist Robert Hirten, M.D., associate professor of medicine and artificial intelligence and human health at the Icahn School of Medicine at Mount Sinai.
Feb 5, 2025